Journal profile · RESPIRATORY SYSTEM
Tuberculosis and Respiratory Diseases
ISSN 1738-3536 · eISSN 2005-6184 · The Korean Academy of Tuberculosis and Respiratory Diseases · Korea, Republic of
Tuberculosis and Respiratory Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); fully open access; APC charged, amount not published; median 101 days to acceptance (80 articles, last 24 months); 80 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Tuberculosis and Respiratory Diseases is published by The Korean Academy of Tuberculosis and Respiratory Diseases and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Chronic Obstructive Pulmonary Disease (COPD) Research, together about 27.5% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Tuberculosis and Respiratory Diseases (Tuberc Respir Dis) is the official journal of the Korean Academy of Tuberculosis and Respiratory Diseases. This journal aims to share clinical and basic scientific knowledge to improve the care of patients with tuberculosis and other respiratory diseases. Its scope includes research on the pathophysiology, diagnosis, and treatment of tuberculosis, respiratory diseases, and critical care medicine. The primary focus is on adult respiratory diseases and pulmonary tuberculosis. Although the regional focus is primarily on Korea, the journal welcomes submissions from researchers around the world. Article types published are Original Article, Review, Image of the Month, Editorial and Letter to the Editor. The journal is published quarterly (January, April, July, and October). TRD is indexed/tracked/covered by Emerging Sources Citation Index (ESCI), KoreaMed, Synapse, KoMCI, PubMed, PubMed Central, CrossRef, SCOPUS, EMBASE, CAS, Google Scholar.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Seong Yong LimPublisher website
Editorial board by country: none in mainland China; most named South Korea 47, United States 8, Hong Kong, China 2, Japan 2, Netherlands 2 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tuberculosis Research and EpidemiologyMedicine12%
- Mycobacterium research and diagnosisMedicine8.9%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine6.6%
- Tracheal and airway disordersMedicine6.5%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.8%
- Diagnosis and treatment of tuberculosisMedicine5.8%
- Medical Imaging and Pathology StudiesMedicine5.4%
- Lung Cancer Diagnosis and TreatmentMedicine5.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPubMedEmbaseCASPublisher website
Other: Google Scholar, Crossref, KoreaMed, KoMCI
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 1.04LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 457OpenAlex ·
- 2-year mean citedness
- 3.2OpenAlex ·
- Self-citation rate
- 13.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 62LetPub ·
Articles by year OpenAlex count · 4,885 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 36 | 8 |
| 2025 | 80 | 80 | 173 |
| 2024 | 60 | 60 | 383 |
| 2023 | 44 | 44 | 446 |
| 2022 | 37 | 37 | 552 |
| 2021 | 53 | 53 | 465 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
101 daysMedian, submission to acceptance · P25–P75 72 days – 153 days
- Acceptance to online
- median 84 days (80 articles)
- Submission to online
- median 198 days
- Sample
- 80 articles with submission and acceptance dates (134 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | KRW 3,500 | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Other fees
- KRW 300
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–10
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
- Graphical abstract
- Optional
Article types accepted10, with length limits
- editorialished in the same issue of the Journal. Editorials should not exceed 1,000 words (excluding references, tables, and figures). An abstract ismain text ≤ 1,000 words
- editorialsManuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor.Length not stated
- images of interestManuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor.Length not stated
- letter to the editorle and space in the TRD is available. A Letter to the Editor should be concise and no longer than 1,000 words. It should have a title, distinct from the title o…main text ≤ 1,000 words
- letters to the editorManuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor.Length not stated
- original articleot restart numbering from each page. A. Original Articles The total length should not exceed 5,000 words (excluding the abstract, references, and table/figure l…main text ≤ 5,000 words
- original articlesManuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor.Length not stated
- othersArticle category Review Original article Images of interest Editorial Letter to the editor OthersLength not stated
- reviewArticle category Review Original article Images of interest Editorial Letter to the editor OthersLength not stated
- reviewsManuscripts types include original articles, reviews, images of interest, editorials, and letters to the editor.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Self-archiving
- Authorship 4. Authorship
In accordance with the ICMJE recommendations defining the role of authors, authorship should be based on all four of the following criteria. Please see the ICMJE Recommendations (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html) for more information. 1) Substantial contributions to the conception or design of the work; or the…
Source ↗Publisher website ·- Conflicts of interest 3. Disclosure of conflict of interest
All authors are required to upload disclosure forms when their manuscript is submitted to the Journal. Please upload these forms along with your other manuscript files, choosing File Designation: "Disclosure of Financial Interest Form(S)." Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). When a manuscrip…
Source ↗Publisher website ·- Data availability 6. Data sharing statement
For clinical trials, authors are required to provide a Data Sharing Statement if data will be shared or not. The Data Sharing Statement form can be downloaded here. The authors are required to fill in a Data Sharing Statement form. Data Sharing Statement should be submitted along with the manuscript. Authors will be asked how the data will be available and if there will be any restrictions on the …
Source ↗Publisher website ·- License & copyright
Copyright transfer form signed electronically by corresponding author at submission. Model summary
Representing all authors, corresponding author needs to sign a copyright transfer form electronically at the time of submission.
Source ↗Publisher website ·- Open access 12. Open access
Open access under Creative Commons Attribution Non-commercial license; immediate availability without embargo period. Model summary
Open access policy Tuberculosis and Respiratory Diseases is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium except commercial use, provided the original work is properly cited. For commercial purposes, the process of permission request to the Edi…
Source ↗Publisher website ·- Peer review 8. Review process
The editorial office checks the paper’s composition and arrangement against the journal’s Author Guidelines to make sure it includes the required sections and stylizations. The editor-in-chief and deputy editors check that the paper is appropriate for the journal and is sufficiently original and interesting. Then, the deputy editors and associate editors handle the peer review process. At this sta…
Source ↗Publisher website ·- Plagiarism 5. Plagiarism and duplicate publication
Plagiarism and duplicate publication checked by CrossCheck upon arrival. Model summary
The submitted manuscript should be original and should not either had been published or submitted to other scientific journals at the same time. In addition, part or all of the accepted manuscript should not be duplicated in other scientific journals without the permission of the editorial committee. The submitted manuscript will be evaluated for possible plagiarism or duplicated publication by Cr…
Source ↗Publisher website ·- Self-archiving
Archived in PubMed Central (PMC)/Europe PMC/PMC Canada from Volume 72, Number 3, 2012. Model summary
Full text of Tuberculosis and Respiratory Diseases has been archived in PubMed Central (PMC)/Europe PMC/PMC Canada (http://www.ncbi.nlm.nih.gov/pmc/journals/1922) from the Volume 72, Number 3, 2012.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- The Korean Academy of Tuberculosis and Respiratory Diseases
- Country or region
- Korea, Republic of
- Language
- English
- ISSN
- 1738-3536
- Electronic ISSN
- 2005-6184
- Latest issue on the website
- Volume 89 (July 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Tuberculosis and Respiratory Diseases
What CAS zone is Tuberculosis and Respiratory Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Tuberculosis and Respiratory Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Tuberculosis and Respiratory Diseases?
The journal's website gives an impact factor of 3.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.6, h-index 48.
How long does peer review take at Tuberculosis and Respiratory Diseases?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 72–153 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Tuberculosis and Respiratory Diseases?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–10; Manuscript length: ≤ 5,000 words; Reference style: Vancouver; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Tuberculosis and Respiratory Diseases based?
Of the 75 board members whose country the journal's board page names, none are in mainland China; the countries named most often are South Korea (47), United States (8) and Hong Kong, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Tuberculosis and Respiratory Diseases?
According to LetPub and DOAJ records, Tuberculosis and Respiratory Diseases is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC, PubMed, Embase and CAS; that list has not been checked against each database.
Is Tuberculosis and Respiratory Diseases open access, and what is the APC?
Tuberculosis and Respiratory Diseases is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .